Clinical trial
CAR-T Cells Targeting B Cell Related Autoimmune Diseases
NCT05459870 is registered in ClinicalTrials.gov with Shenzhen Geno-Immune Medical Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CAR-T Cells Targeting B Cell Related Autoimmune Diseases
- Lead sponsor
- Shenzhen Geno-Immune Medical Institute
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- June 1, 2027
- Completion date
- December 31, 2030
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.